keyboard_arrow_up

Regenerative Medicine Market By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint). However, factors such as stringent regulatory compliance, ethical issues pertaining to stem cell therapy and post implantation rejection are expected to hinder the global market growth during the forecast period. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019. 

Download Free Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. Moreover, tissue engineering is expected to grow at the highest CAGR during the forecast period. 

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. Autogenic bone application segment is expected to grow at the highest CAGR during the forecast period 2013 to 2019.  

North America was the largest market for regenerative medicine bone and joint application in 2012, accounting for largest market share of the total regenerative medicine (bone and joint) market. The regenerative medicine market in North America witnessed significant growth due to increasing demand of bone and joint reconstructive surgeries. Moreover, favorable government initiatives have also supported the growth of the regenerative medicine bone and joint application market in this region. European market was the second largest of the global market in 2012. Rising geriatric population in European Union is one of the major market drivers in this region as the geriatric group is more prone to suffer from arthritis. Moreover, extensive support and funding provided by European government for regenerative medicine would further accentuate the market growth in this region. 

Asia-Pacific was observed to be a promising market for regenerative medicine bone and joint application during the study period owing to the demand of bone graft substitute in this region. This region is considered as an emerging market and is estimated to grow at the highest CAGR from 2013 to 2019. Manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for regenerative medicine bone and joint application. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. In terms of key players the global regenerative medicine bone and joint application market is highly fragmented that comprises of DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute) and Zimmer Holdings, Inc (CopiOs Bone Void Filler).